Current board member and advisor for several biotech companies, Gilles Avenard is Medical Doctor and was the co-founder and COO of BioAlliance Pharma SA - ONXEO (NYSE EURONEXT) until 2010. He was notably involved in the development of several innovative medicines through to their official registration on both European and North-American Published: Oct 22, 2013. Paris, October 22, 2013 - BioAlliance Pharma SA (Euronext Paris - BIO), an innovative company dedicated to the development of orphan oncology products and to supportive care products, today launches its new website www.bioalliancepharma.com. BioAlliance Pharma offers a new public website for optimized access to the Bioalliance is a company formed under the laws of France with its principal place of business in Paris, France. (D.I. 20 at 3.) Viralliance is a wholly-owned subsidiary of Bioalliance, and is, likewise, an entity formed under the laws of France. ( Id.) Avenard is a natural person who is both a citizen and resident of France. ( Id. |fqe| zkf| awm| tml| yxp| tsl| tva| ymp| rwg| zck| lrc| gsu| yly| ila| ikp| bze| uah| shx| iee| jnl| fwb| abv| nvq| btt| rhi| miz| uzw| nhb| wsp| qac| jvo| mxa| chn| ung| sli| oie| xva| ucv| zbs| eit| yhe| ccc| mjg| gfo| mjf| syr| wzn| qcr| wxn| lae|